Target intelligence / Profile preview

Carrier-mediated transport

Molecular classification
Transporter, Biological Process
01

Overview

Carrier-mediated transport is a fundamental biological mechanism describing the movement of solutes across cellular membranes through specific, integral membrane proteins known as transporters or carriers (StatPearls, 2023). This process is distinct from simple diffusion as it is substrate-specific, saturable, and subject to competitive inhibition (NIH, 2022). It includes facilitated diffusion, which occurs down a concentration gradient, and active transport, which utilizes energy to move molecules against a gradient (Wikipedia, 2024). Transporters facilitate the uptake of essential nutrients like glucose and amino acids, the maintenance of ion gradients, and the efflux of metabolic wastes and xenobiotics (PubMed, 2021). In pharmaceutical science, carrier-mediated transport is a key factor in drug pharmacokinetics, determining the absorption, distribution, and excretion profiles of various therapeutic agents (Nature Reviews Drug Discovery, 2010). Although the term refers to a general physiological process rather than a specific molecular entity, individual proteins within the Solute Carrier (SLC) and ATP-Binding Cassette (ABC) families are critical targets for drug development across multiple therapeutic areas.

Other names
Facilitated diffusionActive transportProtein-mediated transportCarrier-mediated diffusionTransporter-mediated transport
02

Mechanism of action

Movement of substances across biological membranes via substrate-specific carrier proteins that undergo conformational changes to facilitate translocation.

03

Biological functions

Nutrient uptakeIon homeostasisWaste excretionDrug absorptionNeurotransmitter reuptakeBlood-brain barrier transport
04

Disease associations

Metabolic disordersCystic fibrosisDrug resistanceNeurological disordersRenal diseasesMalabsorption syndromes
05

Safety considerations

Drug-drug interactions through competitive transporter inhibitionSaturation of transport kinetics leading to non-linear pharmacokineticsGenetic polymorphisms (e.g., in SLCO1B1) affecting drug safety and efficacyToxicity due to off-target inhibition of essential nutrient transporters
06

Interacting drugs

Metformin

5 more in the full profile.

07

Biomarkers

Transporter protein expression levelsTransporter mRNA levelsSolute clearance ratesDrug plasma concentration (Cmax/AUC)

Beyond the preview

Go deeper on Carrier-mediated transport.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Carrier-mediated transport.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call